Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Prostatic Neoplasms × Lenalidomide × Clear all

Phase

Phase 2 4 Phase 1/2 3 Phase 1 3 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Multiple Myeloma 74 Lymphoma, Follicular 16 Lymphoma, Large B-Cell, Diffuse 11 Recurrence 9 Lymphoma 7 Neoplasms, Plasma Cell 6 Lymphoma, B-Cell, Marginal Zone 6 Lymphoma, Non-Hodgkin 5 Neoplasms 4 Hematologic Diseases 4 Leukemia, Lymphocytic, Chronic, B-Cell 3 Disease Progression 3 Smoldering Multiple Myeloma 2 Paraproteinemias 2 Lymphoma, Mantle-Cell 2 Sezary Syndrome 1 Prostatic Neoplasms 1 Polycythemia Vera 1 Plasmacytoma 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Melanoma 1 Lymphoproliferative Disorders 1 Lymphoma, T-Cell, Cutaneous 1 Limb-girdle muscular dystrophy, type 2C 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Immunoproliferative Disorders 1 Heart Failure 1

Interventions

Docetaxel 43 Prednisone 42 Radiotherapy 41 Goserelin 39 Leuprolide 37 bicalutamide 35 enzalutamide 25 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 24 Androgen Antagonists 22 Flutamide 19 Triptorelin Pamoate 17 apalutamide 15 Zoledronic Acid 12 Gonadotropin-Releasing Hormone 12 Abiraterone Acetate 12 gallium 68 PSMA-11 11 abiraterone 11 Radiation 11 Magnetic Resonance Spectroscopy 11 Prednisolone 9 Estramustine 8 Dexamethasone 8 Specimen Handling 7 Chemotherapy, Adjuvant 7 Buserelin 7 orteronel 6 luprolide acetate gel depot 6 darolutamide 6 cabazitaxel 6 Standard of Care 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00988208 2018-04-04

Mainsail

Celgene

Phase 3 Completed

1,059 enrolled 27 charts

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡